• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠中的类固醇21-羟化酶缺乏症。

Steroid 21-hydroxylase deficiency in mice.

作者信息

Gotoh H, Sagai T, Hata J, Shiroishi T, Moriwaki K

机构信息

Department of Cell Genetics, National Institute of Genetics, Shizuoka-ken, Japan.

出版信息

Endocrinology. 1988 Oct;123(4):1923-7. doi: 10.1210/endo-123-4-1923.

DOI:10.1210/endo-123-4-1923
PMID:3262053
Abstract

The enzyme steroid 21-hydroxylase (21-OHase) plays a key role in adrenal steroidogenesis. Defects in this enzyme are responsible for one of the most common inborn errors of metabolism in humans. Duplicated genes for the enzyme are located in the class III region of the major histocompatibility complex (MHC), HLA. In the mouse, the genes encoding 21-OHase have been mapped to the homologous region of the H-2 complex. We previously described an H-2 recombinant haplotype aw18, in which the gene for the complement component C4 and one of the two genes for 21-OHase in the H-2 class III region have been deleted. We now report that newborn aw18 homozygous mice are deficient in 21-OHase activity, and that homozygosity for the aw18 haplotype directly causes death at the early postnatal stage. Morphological changes in the adrenal glands of newborn aw18 homozygotes are also observed. The aw18 recombinant haplotype is expected to serve as a useful and, thus far, unique experimental system to study adrenal steroidogenesis in vivo and as an animal model for the inherited human disease of congenital adrenal hyperplasia.

摘要

类固醇21-羟化酶(21-OHase)在肾上腺类固醇生成中起关键作用。该酶的缺陷是人类最常见的先天性代谢缺陷之一。该酶的重复基因位于主要组织相容性复合体(MHC)HLA的III类区域。在小鼠中,编码21-OHase的基因已定位到H-2复合体的同源区域。我们之前描述了一种H-2重组单倍型aw18,其中H-2 III类区域中的补体成分C4基因和两个21-OHase基因之一已被删除。我们现在报告,新生的aw18纯合子小鼠缺乏21-OHase活性,并且aw18单倍型的纯合性直接导致出生后早期死亡。还观察到新生aw18纯合子肾上腺的形态学变化。aw18重组单倍型有望作为一种有用的、且迄今为止独特的实验系统,用于体内研究肾上腺类固醇生成,并作为先天性肾上腺增生这一遗传性人类疾病的动物模型。

相似文献

1
Steroid 21-hydroxylase deficiency in mice.小鼠中的类固醇21-羟化酶缺乏症。
Endocrinology. 1988 Oct;123(4):1923-7. doi: 10.1210/endo-123-4-1923.
2
Survival of steroid 21-hydroxylase-deficient mice without endogenous corticosteroids after neonatal treatment and genetic rescue by transgenesis as a model system for treatment of congenital adrenal hyperplasia in humans.通过转基因进行新生儿期治疗和基因拯救后,类固醇21-羟化酶缺陷型小鼠在无内源性皮质类固醇的情况下存活,作为人类先天性肾上腺皮质增生症治疗的模型系统。
Endocrinology. 1994 Oct;135(4):1470-6. doi: 10.1210/endo.135.4.7925109.
3
HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation.与HLA相关的先天性肾上腺皮质增生症是由一个有缺陷的基因引起的,该基因编码一种对类固醇21-羟化作用具有特异性的细胞色素P-450。
Proc Natl Acad Sci U S A. 1984 Dec;81(23):7505-9. doi: 10.1073/pnas.81.23.7505.
4
Steroid 21-hydroxylase deficiency and the major histocompatibility complex.类固醇21-羟化酶缺乏症与主要组织相容性复合体
Hum Immunol. 1986 Apr;15(4):404-15. doi: 10.1016/0198-8859(86)90018-2.
5
Lethal deletion of the complement component C4 and steroid 21-hydroxylase genes in the mouse H-2 class III region, caused by meiotic recombination.减数分裂重组导致小鼠H-2Ⅲ类区域中补体成分C4和类固醇21-羟化酶基因的致死性缺失。
Proc Natl Acad Sci U S A. 1987 May;84(9):2819-23. doi: 10.1073/pnas.84.9.2819.
6
Haplotypes of the steroid 21-hydroxylase gene region encoding mild steroid 21-hydroxylase deficiency.编码轻度类固醇21-羟化酶缺乏症的类固醇21-羟化酶基因区域的单倍型。
Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8352-6. doi: 10.1073/pnas.88.19.8352.
7
Congenital adrenal hyperplasia: the molecular basis of 21-hydroxylase deficiency in H-2(aw18) mice.
Endocrinology. 2005 Jun;146(6):2563-74. doi: 10.1210/en.2004-1563. Epub 2005 Feb 24.
8
Gene conversion-like events cause steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.基因转换样事件导致先天性肾上腺皮质增生症中的类固醇21-羟化酶缺乏。
Proc Natl Acad Sci U S A. 1987 Nov;84(22):8091-4. doi: 10.1073/pnas.84.22.8091.
9
HLA associations in 21-hydroxylase deficiency (congenital and late-onset adrenal hyperplasia) in France.
Ann N Y Acad Sci. 1985;458:41-5. doi: 10.1111/j.1749-6632.1985.tb14588.x.
10
Attenuated forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.21-羟化酶缺乏所致先天性肾上腺皮质增生的减毒形式。
J Clin Endocrinol Metab. 1982 Nov;55(5):866-71. doi: 10.1210/jcem-55-5-866.

引用本文的文献

1
Steroid 21-hydroxylase deficiency dysregulates essential molecular pathways of metabolism and energy provision.类固醇21-羟化酶缺乏会使新陈代谢和能量供应的关键分子途径失调。
Biol Open. 2025 Sep 15;14(9). doi: 10.1242/bio.061977. Epub 2025 Sep 8.
2
A Humanized and Viable Animal Model for Congenital Adrenal Hyperplasia--R484Q Mutant Mouse.用于先天性肾上腺皮质增生症的人源化且具有活力的动物模型--R484Q 突变小鼠。
Int J Mol Sci. 2024 May 7;25(10):5062. doi: 10.3390/ijms25105062.
3
AAV-delivered hepato-adrenal cooperativity in steroidogenesis: Implications for gene therapy for congenital adrenal hyperplasia.
腺相关病毒介导的类固醇生成中肝-肾上腺协同作用:对先天性肾上腺皮质增生症基因治疗的意义。
Mol Ther Methods Clin Dev. 2024 Mar 12;32(2):101232. doi: 10.1016/j.omtm.2024.101232. eCollection 2024 Jun 13.
4
[Gene and cell therapy of adrenal pathology: achievements and prospects].[肾上腺疾病的基因与细胞治疗:成就与展望]
Probl Endokrinol (Mosk). 2021 Dec 2;67(6):80-89. doi: 10.14341/probl12818.
5
Transforming growth factor-β (TGF-β) pathway abnormalities in tenascin-X deficiency associated with CAH-X syndrome.与先天性挛缩性多指(趾)畸形X综合征相关的腱生蛋白-X缺乏症中的转化生长因子-β(TGF-β)信号通路异常。
Eur J Med Genet. 2014 Feb;57(2-3):95-102. doi: 10.1016/j.ejmg.2013.12.004. Epub 2013 Dec 28.
6
Aged PROP1 deficient dwarf mice maintain ACTH production. aged PROP1 缺陷型 dwarf 小鼠维持 ACTH 的产生。
PLoS One. 2011;6(12):e28355. doi: 10.1371/journal.pone.0028355. Epub 2011 Dec 1.
7
Novel basic and clinical aspects of congenital adrenal hyperplasia.先天性肾上腺皮质增生症的新基础与临床研究进展
Rev Endocr Metab Disord. 2001 Aug;2(3):289-96. doi: 10.1023/a:1011520600476.
8
The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C.腱生蛋白-X的分布是独特的,且常常与腱生蛋白-C的分布相反。
J Cell Biol. 1994 Apr;125(2):483-93. doi: 10.1083/jcb.125.2.483.